Effect of the activation of the kinin-forming system on the potency of chlorpromazine.
D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects* / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D003864:Depression, Chemical; D004357:Drug Synergism; D004789:Enzyme Activation; D007610:Kallikreins / Q000494:pharmacology*; D007704:Kininogens / Q000097:blood; D007705:Kinins / Q000378:metabolism*; D008297:Male; D051379:Mice; D051381:Rats; D013268:Stimulation, Chemical
D007704:Kininogens; D007705:Kinins; D007611:Aprotinin; D007610:Kallikreins; D001920:Bradykinin; D002746:Chlorpromazine